Quick Answer
XBiotech Inc. reported Net Income Loss of -$45.54 million for the year ending 2025.
- XBiotech Inc. showed a decrease of -18.2% in Net Income Loss from 2024 to 2025.
- This data is from XBiotech Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), XBiotech Inc.'s Net Income Loss has declined by 358.7%.
- Historical annual values: Fiscal year 2025: -$45.54 million | Fiscal year 2024: -$38.53 million | Fiscal year 2023: -$24.56 million | Fiscal year 2022: -$32.90 million | Fiscal year 2021: -$17.41 million | Fiscal year 2020: -$11.22 million | Fiscal year 2019: $668.63 million | Fiscal year 2018: -$21.14 million | Fiscal year 2017: -$33.15 million | Fiscal year 2016: -$52.76 million | Fiscal year 2015: -$37.48 million | Fiscal year 2014: -$21.72 million | Fiscal year 2013: -$9.93 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: